The global dried blood spot collection cards market size is expected to reach USD 337.3 million by the year 2026, expanding at a CAGR of 3.5%, according to a new report by Grand View Research, Inc. Key drivers of the market include an increase in the use of dried blood spot (DBS) cards in newborn screening and for serological diagnostics of infectious and autoimmune diseases, among other applications.
Use of DBS cards in newborn screening is expected to boost market growth during the forecast period. According to NIH, it is estimated that around 4 million infants were screened in the U.S. in 2017. Additionally, data from the CDC indicates that about 12,500 infants were diagnosed with congenital diseases that were detected through newborn screening tests. This states that almost 1 out of every 300 infants screened were eventually diagnosed with one of the congenital diseases. Therefore, increasing awareness has facilitated a rise in demand for DBS cards for the detection of congenital diseases in infants which is anticipated to fuel the market growth during the forecast period.
The usage of DBS for serological diagnostics of infectious or autoimmune diseases is also anticipated to fuel the market growth during the forecast period. DBS offers a cost-effective solution for diagnosis of infectious diseases as these collection cards can be easily collected, transported and preserved in settings with minimal infrastructural facilities. Global health settings, especially in the rural areas, lack the necessary infrastructure for quality assured venipuncture sparks significant interest in the usage of DBS cards for diagnosis of infectious or autoimmune diseases.
Browse Details of Report @ https://www.grandviewresearch.com/industry-analysis/dried-blood-spot-collection-cards-market
In August 2017, PerkinElmer launched PerkinElmer Genetics' clinical genomics services. Whole exome sequencing and whole-genome sequencing were offered in all their laboratories across India, U.S., and China. PerkinElmer’s genome lab testing platform offers diagnostic testing and screening, newborn screening using dried blood spot cards and generation sequencing of rare inherited diseases. Therefore, the increase in strategic initiatives undertaken by major market players is expected to increase the demand and usage of DBS cards for newborn screening during the forecast period.